Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

IXS provides a robust institutional-grade SaaS platform that facilitates the tokenization, issuance, and compliant trading of real-world assets on blockchain. The platform’s infrastructure includes the IXS Launchpad for primary offerings and an IXS DEX for compliant secondary market trading of tokenized RWAs. Regulated under a licensed framework with strong KYC/AML and security token compliance, IXS ensures trustworthy and secure asset management for institutions. Strategic partnerships with top centralized exchanges and LINE’s extensive user base enable wide onchain distribution and adoption. IXS is led by a seasoned team with deep expertise in blockchain, capital markets, and regulatory compliance. This comprehensive ecosystem supports both institutions needing compliant asset issuance and individuals seeking access to onchain financial opportunities with fractional ownership and liquidity. With over 220 million users influenced by its platform, IXS aims to drive mainstream adoption of institutional RWAs. It offers a seamless, secure, and scalable solution for connecting traditional finance with the blockchain world.

Description

Synthetix is a protocol for the issuance of decentralized synthetic assets operating on the Ethereum blockchain. These synthetic assets, known as Synths, are backed by the Synthetix Network Token (SNX), which, when locked within the contract, allows for the creation of these assets. The model of pooled collateral permits users to exchange Synths directly through the smart contract, eliminating the necessity for counterparties. This innovative approach addresses common problems such as liquidity and slippage that decentralized exchanges often face. Currently, Synthetix provides synthetic representations of fiat currencies, cryptocurrencies (both long and short), as well as various commodities. SNX holders are motivated to stake their tokens, as they earn a proportional share of the fees accrued from transactions on Synthetix.Exchange, reflecting their stake in the ecosystem. This right to engage with the network and earn fees from Synth transactions contributes to the intrinsic value of the SNX token. Notably, traders do not need to hold SNX in order to participate in trading on Synthetix.Exchange, enhancing accessibility for a broader audience. By doing so, Synthetix opens the door for more users to engage in trading without needing to invest in the underlying token initially.

API Access

Has API

API Access

Has API

Screenshots View All

No images available

Screenshots View All

Integrations

1inch
1inch Wallet
Armor.Fi
Blocknative
CoinLedger
Crypto APIs
Enzyme
Kriptomat
Ledger Nano X
PieDAO
Token Terminal
Tradesilvania
Ubeswap
YouHodler
vfat.tools

Integrations

1inch
1inch Wallet
Armor.Fi
Blocknative
CoinLedger
Crypto APIs
Enzyme
Kriptomat
Ledger Nano X
PieDAO
Token Terminal
Tradesilvania
Ubeswap
YouHodler
vfat.tools

Pricing Details

No price information available.
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

IXS

Founded

2021

Country

Bahamas

Website

www.ixs.finance/

Vendor Details

Company Name

Synthetix

Founded

2017

Country

Australia

Website

synthetix.io

Product Features

Alternatives

Vezora Reviews

Vezora

nextChainX

Alternatives

Injective Reviews

Injective

Injective Labs